Real-World Data on the Incidence of Macrovascular Complications in Japanese Patients with Type 2 Diabetes: The Sitagliptin Registration Type 2 Diabetes-Juntendo Collaborating Project.

MLA

Ohmura, Hirotoshi, et al. “Real-World Data on the Incidence of Macrovascular Complications in Japanese Patients with Type 2 Diabetes: The Sitagliptin Registration Type 2 Diabetes-Juntendo Collaborating Project.” Diabetes Therapy, vol. 10, no. 3, June 2019, pp. 1099–111. EBSCOhost, https://doi.org/10.1007/s13300-019-0626-2.

APA

Ohmura, H., Mita, T., Matsuoka, J., Nojiri, S., Nishizaki, Y., Watada, H., & Daida, H. (2019). Real-World Data on the Incidence of Macrovascular Complications in Japanese Patients with Type 2 Diabetes: The Sitagliptin Registration Type 2 Diabetes-Juntendo Collaborating Project. Diabetes Therapy, 10(3), 1099–1111. https://doi.org/10.1007/s13300-019-0626-2

Chicago

Ohmura, Hirotoshi, Tomoya Mita, Joe Matsuoka, Shuko Nojiri, Yuji Nishizaki, Hirotaka Watada, and Hiroyuki Daida. 2019. “Real-World Data on the Incidence of Macrovascular Complications in Japanese Patients with Type 2 Diabetes: The Sitagliptin Registration Type 2 Diabetes-Juntendo Collaborating Project.” Diabetes Therapy 10 (3): 1099–1111. doi:10.1007/s13300-019-0626-2.